Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000360314

Medchemexpress LLC Remogliflozin etabonate (GSK189075) | 442201-24-3 | 99.64% | 522.59 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY149455MG

Encompass_Preferred

Remogliflozin etabonate (GSK189075) is an orally active, selective, and low-affinity sodium glucose cotransporter (SGLT2) inhibitor. It functions as a proagent derived from benzylpyrazole glucoside and is metabolized into its active form, Remogliflozin, within the body. This compound has demonstrated antidiabetic efficacy in rodent models.

  • Orally active and selective SGLT2 inhibitor
  • Functions as a proagent of Remogliflozin
  • Exhibits antidiabetic efficacy in rodent models

Catalog No. 50-003-60314


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.